Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06HIJ
|
|||
| Drug Name |
PMID27607364-Compound-60
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT LEHMANN, Lutz THIELE, Andrea HEINRICH, Tobias VOLLMER, Sonja
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H25FN2O5
|
|||
| Canonical SMILES |
CC(=O)N(CC1=C(C=CC(=C1)OC)OCCF)C2=C(N=CC=C2)OC3=CC=C(C=C3)OC
|
|||
| InChI |
1S/C24H25FN2O5/c1-17(28)27(16-18-15-21(30-3)10-11-23(18)31-14-12-25)22-5-4-13-26-24(22)32-20-8-6-19(29-2)7-9-20/h4-11,13,15H,12,14,16H2,1-3H3/i25-1
|
|||
| InChIKey |
WDCDJYGFOQXTQD-FNNGWQQSSA-N
|
|||
| CAS Number |
CAS 1207345-42-3
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
| Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| HTLV-I infection | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.